Panagora Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Panagora Asset Management’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-19,785	Closed	-$742K	–	1254
2023 Q1	$742K	Hold	19,785	–	–	﹤0.01%	956
2022 Q4	$554K	Sell	19,785 -4,883	-20%	-$142K	﹤0.01%	1119
2022 Q3	$693K	Buy	24,668 +16,382	+198%	+$535K	﹤0.01%	1018
2022 Q2	$288K	Sell	8,286 -3,741	-31%	-$133K	﹤0.01%	1315
2022 Q1	$432K	Sell	12,027 -17,938	-60%	-$509K	﹤0.01%	1260
2021 Q4	$698K	Buy	+29,965	New	+$613K	﹤0.01%	1079
2021 Q3	–	Sell	-7,916	Closed	-$160K	–	1728
2021 Q2	$160K	Sell	7,916 -1,276	-14%	-$24K	﹤0.01%	1720
2021 Q1	$168K	Hold	9,192	–	–	﹤0.01%	1763
2020 Q4	$185K	Buy	9,192 +1,276	+16%	+$24.8K	﹤0.01%	1620
2020 Q3	$148K	Buy	+7,916	New	+$159K	﹤0.01%	1639
2018 Q2	–	Sell	-31,820	Closed	-$597K	–	2369
2018 Q1	$597K	Buy	+31,820	New	+$598K	﹤0.01%	1334
2017 Q1	–	Sell	-33,916	Closed	-$625K	–	2372
2016 Q4	$625K	Sell	33,916 -47,863	-59%	-$931K	﹤0.01%	1369
2016 Q3	$1.55M	Buy	81,779 +51,281	+168%	+$931K	0.01%	1023
2016 Q2	$492K	Sell	30,498 -15,741	-34%	-$222K	﹤0.01%	1371
2016 Q1	$555K	Sell	46,239 -3,233	-7%	-$38.1K	﹤0.01%	1317
2015 Q4	$704K	Buy	49,472 +14,835	+43%	+$196K	﹤0.01%	1191
2015 Q3	$405K	Buy	34,637 +32,820	+1,806%	+$492K	﹤0.01%	1387
2015 Q2	$32K	Buy	+1,817	New	+$28.3K	﹤0.01%	2229

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Panagora Asset Management's AMPH Position: Q2 2023 in Review

Panagora Asset Management sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2023, closing a stake of 19,785 shares — an estimated $742K sold.

Panagora Asset Management first reported a position in AMPH in Q2 2015 and held it in 18 quarters. The position peaked at $1.55M in Q3 2016. 245 funds tracked by Wall St. Rank hold AMPH as of Q2 2023.

Panagora Asset Management reported no remaining Amphastar Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Panagora Asset Management sold 19,785 Amphastar Pharmaceuticals shares in Q2 2023, an estimated $742K.
Panagora Asset Management first reported a position in Amphastar Pharmaceuticals in Q2 2015 and held it in 18 quarters.
Panagora Asset Management's Amphastar Pharmaceuticals position peaked at $1.55M in Q3 2016.
245 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2023.

Based on Panagora Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.